Cancer screening is the only circumstance in which apparently healthy people subject themselves purposely to an agent ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
May 25, 2016 — Positron emission tomography (PET) is used commonly in the diagnosis of suspected lung cancer. Computed ...
May 12, 2016 — A buildup of plaque and dysfunctional proteins in the brain are hallmarks of Alzheimer’s disease. While ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
In the world of molecular imaging, PET/MR is a wild card. But it’s a wild card that’s ready to be played. Three major ...
April 13, 2016 — Using positron emission tomography (PET) to guide chemotherapy treatment significantly increases the ...
March 29, 2016 —A promising new discovery by University of California Los Angeles (UCLA) scientists could lead to a new ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
March 3, 2016 — Participating dementia specialists may now enroll patients in the Imaging Dementia—Evidence for Amyloid ...
February 23, 2016 — The National Institutes of Health recently bestowed a $1.5 million grant on a Washington University ...
February 22, 2016 — A new study suggests that one approach to watching for lung cancer’s return is being inappropriately ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
The Radiological Society of North America (RSNA) presented its fourth Alexander R. Margulis Award for Scientific ...
October 19, 2015 — Siemens’ PETNET Solutions Inc., a wholly owned subsidiary of Siemens Healthcare, will formulate the ...
October 2, 2015 — Siemens’ PETNET Solutions has received Abbreviated New Drug Application (ANDA) approval from the U.S ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
September 23, 2015 — New research describes a method, tested in rats, that may someday allow healthcare providers to ...
September 16, 2015 — A novel radiopharmaceutical probe developed at Massachusetts General Hospital (MGH) has the ...
August 21, 2015 — A molecular imaging biomarker is able to detect fast-growing primary prostate cancer and distinguish ...
July 31, 2015 — Researchers at the University of Kentucky’s Sanders-Brown Center on Aging are on the hunt for biomarkers ...
June 29, 2015 - The Global Nuclear Medicine Diagnostics Market report from Mordor Intelligence revealed that North ...
June 12, 2015 - A first-in-human study shows how a powerful new drug finds and attaches itself to the ovarian and ...
June 12, 2015 - Neuroinflammation caused by a reactive immune system could be tripping off the neurodegeneration seen in ...
June 12, 2015 - Siemens' PETNET Solutions Inc. has entered into a nationwide agreement with U.K.-based Blue Earth ...
June 01, 2016 